Subscribe to Newsletter
Subspecialties Cornea / Ocular Surface

Trachomatous Trichiasis Triptych

Trachomatous trichiasis (TT), a condition caused by repeated infections from the trachoma bacteria, leads to the inward turning of the eyelashes, causing corneal damage and potentially blindness. In trachoma-endemic regions, the primary treatment for TT is surgery. To determine how different surgical techniques and incision heights affect TT surgery outcomes, an inter-university team of researchers designed the “Maximizing Trichiasis Surgery Success (MTSS) trial.”

The trial, conducted in Ethiopia, randomized 4,914 individuals with unoperated TT into three surgical groups: bilamellar tarsal rotation (BLTR) with a 3 mm incision height (BLTR-3), BLTR with a 5 mm incision height (BLTR-5), and posterior lamellar tarsal rotation (PLTR). The study aimed to determine the best surgical approach of the three by evaluating the primary outcome of post-operative trichiasis (PTT) and secondary outcomes, such as eyelid contour abnormalities (ECA) and granuloma formation, over a one-year follow-up period.

The results showed that the BLTR-5 led to significantly higher PTT rates (22 percent) compared with BLTR-3 (15 percent) and PLTR (13.1 percent). That said, BLTR-5 did yield lower granuloma formation than both BLTR-3 and PLTR. ECAs were also least common in BLTR-5 (6.1 percent; compared with 11.2 percent in PLTR – the highest ECA rate) – a fact that could be “explained by the larger fragment being more difficult to distort into an ECA than the thinner, more bendable fragment created by a lower incision.”

Overall, the trial’s findings indicate that modifying incision height to 5 mm does not improve overall surgical success and may also increase the risk of recurrent trichiasis. The authors do note, however, that due to the small number of surgeons (seven) evaluated in the study, more evidence and further research is needed to fully assess the impact of these techniques for maximizing trichiasis surgery success.

NEWS

The Ophthalmologist Presents:

The Ophthalmologist Weekly Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
The Ophthalmologist
Related Case Studies
The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Finding Ocular Surface Inflammation

| Contributed by Quidel

Related Product Profiles
Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Cornea / Ocular Surface
Preservative-Free Cyclosporine 0.1% Ophthalmic Emulsion

| Contributed by ImprimisRx

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: